Ligand validation:5JF2

IMD: IMIDAZOLE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5JF2_IMD_A_303	35%	79%	0.19	0.88	0.27	0.59	-	-	3	0	100%	1
5JF7_IMD_A_303	76%	66%	0.116	0.954	0.66	0.63	-	-	0	0	100%	1
5JF8_IMD_A_303	67%	76%	0.121	0.93	0.55	0.39	-	-	1	0	100%	1
5JEX_IMD_A_301	55%	67%	0.159	0.928	0.67	0.6	-	-	0	0	100%	1
5JF4_IMD_A_303	47%	64%	0.201	0.942	0.41	0.94	-	-	3	0	100%	1
5JF3_IMD_A_303	32%	74%	0.194	0.867	0.39	0.59	-	-	0	0	100%	1
3U9W_IMD_A_2009	100%	54%	0.038	0.985	0.43	1.32	-	1	0	0	100%	1
3NN1_IMD_B_243	99%	76%	0.049	0.986	0.35	0.59	-	-	0	0	100%	1
2ASN_IMD_X_202	99%	66%	0.051	0.987	0.4	0.87	-	-	1	0	100%	1
3EBZ_IMD_B_301	99%	63%	0.059	0.99	0.35	1.03	-	-	0	0	100%	1
6LY4_IMD_A_502	99%	75%	0.059	0.989	0.23	0.73	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.